Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis

Rheumatology International

Volumn 33, Issue 3, 2013, Pages 601-605

  Moghimi, Jamileh ^a   Ghorbani, Raheb ^a   Hasani, Farnaz ^a   Sheikhvatan, Mehrdad ^b  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti cyclic citrullinated peptide; Antibody; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IRAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 84879684705     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2414-4     Document Type: Article

References (27)

1. Miriovsky BJ, Michaud K, Thiele GM et al (2010) Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Ann Rheum Dis 69:1292-1297
2. Raptopoulou A, Sidiropoulos P, Katsouraki M et al (2007) Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit Rev Clin Lab Sci 44:339-363
3. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845-851
4. Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT (2007) Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit Rev Clin Lab Sci 44:339-363
5. Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085-1089
6. Machold KP, Stamm TA, Nell VP et al (2007) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first year of disease. Rheumatology (Oxford) 46:342-349
7. Berglin E, Johansson T, Sundin U et al (2006) Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 65:453-458
8. Lindqvist E, Eberhardt K, Bendtzen K et al (2005) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64:196-201
9. van der Helm-van Mil AH, Verpoort KN, Breedveld FC et al (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:949-958
10. Rönnelid J, Wick MC, Lampa J et al (2005) Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 years follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744-1749
11. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:144-163
12. Kroot EJ, de Jong BA, van Leeuwen MA et al (2000) The prognostic value of anti-cyclic itrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831-1835
13. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
14. Singwe-Ngandeu M, Finckh A, Bas S, Tiercy JM, Gabay C (2010) Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients. Arthritis Res Ther 12:36
15. Predeteanu D, Varzaru L, Balanescu A et al (2009) Anti-cyclic citrullinated peptide antibodies-activity markers in rheumatoid arthritis. J Med Life 2:36-41
16. Hwang SM, Kim JO, Yoo YM et al (2010) Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis. Clin Chem Lab Med 48:225-230
17. Heidari B, Firouzjahi A, Heidari P, Hajian K (2009) The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis. Ann Saudi Med 29:467-470
18. Aflaky E, Shenavandeh S, Ashraf MJ (2010) A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients Iran. Rheumatol Int 30:461-466
19. Whiting PF, Smidt N, Sterne JA et al (2010) Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Int Med 152:456-464
20. Sockalingam S, Khuan CS, Sthaneshwar P (2009) Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity. Int J Rheum Dis 12:211-215
21. Nishimura K, Sugiyama D, Kogata Y et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Int Med 146:797-808
22. Mimori T (2005) Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Int Med 44:1112-1126
23. Pietrapertosa D, Tolusso B, Gremese E et al (2010) Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios. Clin Chem Lab Med 48:829-834
24. Hodkinson B, Meyer PW, Musenge E et al (2010) The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol 29:615-618
25. Li H, Song W, Li Y et al (2010) Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29:413-417
26. Lin HK, Lan JL, Chen DY et al (2008) The diagnostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis. Formos J Rheum 22:68-73
27. Choi SW, Lim MK, Shin DH, Park JJ, Shim SC (2005) Diagnostic performances of anti-cyclic citrullinated peptides antibody and antiWlaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci 20:473-478